DG Health Immediate Release Mucus Relief 400 mg/1
Guaifenesin · TABLET · Reese Pharmaceutical Co
DG Health Immediate Release Mucus Relief is a tablet containing guaifenesin at 400 mg/1, taken oral. Manufactured by Reese Pharmaceutical Co.
Key Facts
- Brand Name
- DG Health Immediate Release Mucus Relief
- Generic Name
- Guaifenesin
- NDC Code (Product)
10956-059- Manufacturer
- Reese Pharmaceutical Co
- Strength
- 400 mg/1
- Dosage Form
- TABLET
- Route
- ORAL
- Marketing Status
- Application #
- M012
- Drug Class
- Expectorant [EPC]
- Marketing Start
- 08/01/2012
Recall History
No Recall HistoryFrequently Asked Questions
What is DG Health Immediate Release Mucus Relief used for?
DG Health Immediate Release Mucus Relief contains Guaifenesin. It is a tablet taken oral. Consult your doctor for specific uses.
Is DG Health Immediate Release Mucus Relief a controlled substance?
DG Health Immediate Release Mucus Relief is not classified as a controlled substance by the DEA.
What is the generic name for DG Health Immediate Release Mucus Relief?
The generic name for DG Health Immediate Release Mucus Relief is Guaifenesin. There are 12 other brand versions of Guaifenesin.
What is the NDC code for DG Health Immediate Release Mucus Relief 400 mg/1?
The NDC (National Drug Code) for DG Health Immediate Release Mucus Relief 400 mg/1 is 10956-059, listed by Reese Pharmaceutical Co.
Other Guaifenesin Brands
See all →- Guaifenesin and Dextromethorphan Hydrobromide10 mg/5mL72162-2277
- basic care mucus er600 mg/172288-298
- basic care mucus er max1200 mg/172288-613
- Pharbinex-DM20 mg/173057-381
- Mucus Relief DM Extended Release Caplets30 mg/10536-1161
- MUCUS RELIEF - DM MAXIMUM STRENGTH60 mg/173581-405
- BACZOL EXPECTORANT200 mg/5mL76864-209
- Guaifenesin and Pseudoephedrine HCl600 mg/179481-1002
- Meijer Adult Mucus Plus chest congestion200 mg/10mL79481-7430
- Tussin Mucus and Chest Congestion Sugar Free200 mg/10mL82568-0012
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)